A Randomized Controlled Study Comparing Once-Weekly to Every-2-Week and Every-4-Week Dosing of Epoetin Alfa in CKD Patients with Anemia

Background and objectives: Extended-interval dosing of epoetin alfa (EPO) is commonly used to treat anemia in patients with chronic kidney disease (CKD). This study aimed to demonstrate that EPO dosed every 2 weeks (Q2W) and every 4 weeks (Q4W) was noninferior to once-weekly (QW) dosing. Design, set...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pergola, Pablo E., Gartenberg, Gary, Fu, Min, Sun, Steven, Wolfson, Marsha, Bowers, Peter
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Nephrology 2010
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2849701/
https://ncbi.nlm.nih.gov/pubmed/20185602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06770909
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky